Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Novartis Pharmaceuticals | Novartis | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
InterMune Inc. | Roche | off-label or unapproved promotion of medical products | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000 |
Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2017 | private lawsuit-federal | $6,750,000 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
Aventis | Sanofi | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
Novartis | Novartis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,000,000 |
Forest Laboratories Inc. | AbbVie | False Claims Act and related | 2019 | IL-AG | $7,089,034 |
Medicis Pharmaceutical | Bausch Health | employment discrimination | 2016 | private lawsuit-federal | $7,150,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | DOJ_CIVIL | $7,300,000 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
Allergan Ltd. | AbbVie | off-label or unapproved promotion of medical products | 2022 | RI-AG | $7,500,000 |
Galena Biopharma Inc. | SELLAS Life Sciences Group | False Claims Act and related | 2017 | USAO | $7,550,000 |
Eisai | Eisai | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $7,900,000 |
Akorn Operating Company LLC | Akorn Inc. | False Claims Act and related | 2022 | DOJ_CIVIL | $7,900,000 |
Novartis Corporation and Alcon Laboratories | Novartis | employment discrimination | 2016 | private lawsuit-federal | $8,000,000 |
Warner Chilcott | AbbVie | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $8,000,000 |
Daiichi Sankyo | Daiichi Sankyo | employment discrimination | 2016 | private lawsuit-federal | $8,200,000 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
Merck | Merck | drug or medical equipment safety violation | 2013 | PA-AG | $8,250,000 |
Schering-Plough Corporation | Merck | benefit plan administrator violation | 2010 | private lawsuit-federal | $8,500,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Endo Pharmaceuticals | Endo International | Controlled Substances Act violation | 2020 | OK-AG | $8,750,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $8,900,000 |
Novo Nordisk A/S | Novo Holdings A/S | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $9,000,000 |
UCB Chemicals Corporation | UCB | price-fixing or anti-competitive practices | 2001 | private lawsuit-federal | $9,000,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $9,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Amgen Inc. | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Dey, Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Fujisawa Healthcare, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Hoechst Marion Roussel | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Immunex Corporation | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Pharmacia Corporation | Pfizer | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
ZLB Behring, L.L.C. | CSL Limited | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
DePuy Synthes, Inc. | Johnson & Johnson | False Claims Act and related | 2023 | DOJ_CIVIL | $9,750,000 |
Biogen Inc. | Biogen | benefit plan administrator violation | 2024 | private lawsuit-federal | $9,750,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,756,164 |
Medicis Pharmaceutical Corporation | Bausch Health | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $9,800,000 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
CSL Plasma Inc. | CSL Limited | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
Ethicon | Johnson & Johnson | consumer protection violation | 2023 | KY-AG | $9,900,000 |
Biovail Corporation | Bausch Health | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Indivior, Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2020 | FTC | $10,000,000 |
Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $10,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $10,000,000 |
Bausch & Lomb Inc. | Bausch Health | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $10,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
Merck & Co. | Merck | consumer protection violation | 2013 | private lawsuit-federal | $10,000,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
Forest Laboratories Inc. | AbbVie | consumer protection violation | 2014 | private lawsuit-federal | $10,350,000 |
Merck & Co., Inc. | Merck | benefit plan administrator violation | 2012 | private lawsuit-federal | $10,400,000 |
Warner Chilcott PLC | AbbVie | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,600,000 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
Pharmavite LLC | Otsuka Pharmaceutical | consumer protection violation | 2017 | private lawsuit-federal | $10,975,000 |
Eisai Inc. | Eisai | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
Dava Pharmaceuticals Inc. | Endo International | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Dava Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
Hoffmann-La Roche Inc. | Roche | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $11,000,000 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
Novartis Pharmaceuticals Corporation | Novartis | kickbacks and bribery | 2020 | CA-AG | $11,800,000 |
Sanofi-Aventis U.S., LLC | Sanofi | False Claims Act and related | 2020 | USAO | $11,850,000 |
SciClone Pharmaceuticals | SciClone Pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $12,000,000 |
Hoechst AG | Sanofi | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Schering-Plough Corporation | Merck | benefit plan administrator violation | 2012 | private lawsuit-federal | $12,250,000 |
Incyte Corporation | Incyte Corp. | False Claims Act and related | 2021 | DOJ_CIVIL | $12,600,000 |
Sandoz, Inc. | Sandoz Group | HHS civil monetary penalties | 2015 | HHSOIG | $12,640,000 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Alexion Pharmaceuticals Inc. | AstraZeneca | False Claims Act and related | 2019 | DOJ_CIVIL | $13,000,000 |
Eli Lilly and Co. | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |